Drug intelligence / Profile preview

Suvaro

Development stage
Phase 4
Lead developer
BC World Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

Suvaro is a brand of rosuvastatin calcium, a synthetic lipid-lowering agent in the statin class, specifically available in an orally disintegrating tablet (ODT) formulation in South Korea. It is used to treat dyslipidemia, hypercholesterolemia, and hypertriglyceridemia. As a selective and competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, it blocks the conversion of HMG-CoA to mevalonate, the rate-limiting step in cholesterol biosynthesis. This inhibition primarily occurs in the liver, leading to increased expression of LDL receptors on the surface of hepatocytes, which enhances the uptake and catabolism of LDL from the blood. The ODT version, developed by BCWorld Pharm and marketed by Hanlim Pharm, is designed to dissolve rapidly on the tongue without water, providing a convenient alternative for patients with dysphagia or those seeking improved adherence through more flexible administration.

Brand names
SuvaroSuvaro ODTSuvaro ODSuvaro Odi
Other names
rosuvastatin orally disintegrating tabletrosuvastatin calcium ODT
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on Suvaro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suvaro.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call